$3.23
+0.06
(+1.89%)▲
Insights on Beauty Health Co/the
Revenue is down for the last 3 quarters, 117.5M → 96.8M (in $), with an average decrease of 8.9% per quarter
Netprofit is up for the last 2 quarters, -73.8M → -9.4M (in $), with an average increase of 685.1% per quarter
In the last 1 year, Colgate-palmolive Co. has given 14.3% return, outperforming this stock by 83.6%
3.25%
Downside
Day's Volatility :6.79%
Upside
3.65%
58.2%
Downside
52 Weeks Volatility :87.91%
Upside
71.08%
Period | Beauty Health Co/the | Sector (Consumer Staples) | Index (Russel 2000) |
---|---|---|---|
3 Months | 11.0% | 2.0% | 0.0% |
6 Months | -26.26% | 10.0% | 0.0% |
1 Year | -69.3% | -1.3% | 1.7% |
3 Years | -74.14% | 7.8% | -22.3% |
Market Capitalization | 377.7M |
Book Value | $0.48 |
Earnings Per Share (EPS) | -0.76 |
PEG Ratio | 0.95 |
Wall Street Target Price | 4.56 |
Profit Margin | -25.16% |
Operating Margin TTM | -18.96% |
Return On Assets TTM | -8.47% |
Return On Equity TTM | -88.43% |
Revenue TTM | 398.0M |
Revenue Per Share TTM | 3.02 |
Quarterly Revenue Growth YOY | -1.3% |
Gross Profit TTM | 250.3M |
EBITDA | -96.2M |
Diluted Eps TTM | -0.76 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.1 |
EPS Estimate Next Year | 0.04 |
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Next Quarter | -0.06 |
What analysts predicted
Upside of 41.18%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 112.3M | - |
Net Income | -317.0K | - |
Net Profit Margin | -0.28% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 166.6M | ↑ 48.36% |
Net Income | -1.6M | ↑ 416.72% |
Net Profit Margin | -0.98% | ↓ 0.7% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 119.1M | ↓ 28.53% |
Net Income | -29.2M | ↑ 1681.14% |
Net Profit Margin | -24.5% | ↓ 23.52% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 260.1M | ↑ 118.39% |
Net Income | -375.1M | ↑ 1185.72% |
Net Profit Margin | -144.22% | ↓ 119.72% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 365.9M | ↑ 40.68% |
Net Income | 44.2M | ↓ 111.79% |
Net Profit Margin | 12.09% | ↑ 156.31% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 398.0M | ↑ 8.78% |
Net Income | -100.1M | ↓ 326.38% |
Net Profit Margin | -25.16% | ↓ 37.25% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 88.8M | ↓ 14.24% |
Net Income | 131.0K | ↓ 97.93% |
Net Profit Margin | 0.15% | ↓ 5.95% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 98.1M | ↑ 10.52% |
Net Income | 3.8M | ↑ 2812.21% |
Net Profit Margin | 3.89% | ↑ 3.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 86.3M | ↓ 12.06% |
Net Income | -22.2M | ↓ 681.91% |
Net Profit Margin | -25.72% | ↓ 29.61% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 117.5M | ↑ 36.15% |
Net Income | 3.4M | ↓ 115.15% |
Net Profit Margin | 2.86% | ↑ 28.58% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 97.4M | ↓ 17.11% |
Net Income | -73.8M | ↓ 2293.82% |
Net Profit Margin | -75.77% | ↓ 78.63% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 96.8M | ↓ 0.62% |
Net Income | -9.4M | ↓ 87.26% |
Net Profit Margin | -9.71% | ↑ 66.06% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 226.4M | - |
Total Liabilities | 227.6M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 222.8M | ↓ 1.55% |
Total Liabilities | 252.8M | ↑ 11.09% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 446.95% |
Total Liabilities | 916.5M | ↑ 262.55% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.0B | ↓ 17.22% |
Total Liabilities | 837.4M | ↓ 8.63% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 929.1M | ↓ 7.91% |
Total Liabilities | 869.7M | ↑ 3.86% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↓ 9.07% |
Total Liabilities | 846.9M | ↓ 1.82% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↓ 8.68% |
Total Liabilities | 837.4M | ↓ 1.12% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 994.9M | ↓ 1.39% |
Total Liabilities | 847.3M | ↑ 1.18% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↑ 1.27% |
Total Liabilities | 845.6M | ↓ 0.2% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 973.1M | ↓ 3.41% |
Total Liabilities | 883.2M | ↑ 4.45% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 929.1M | ↓ 4.52% |
Total Liabilities | 869.7M | ↓ 1.53% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -895.0K | - |
Investing Cash Flow | -8.4M | - |
Financing Cash Flow | 11.2M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.7M | ↓ 293.07% |
Investing Cash Flow | -12.5M | ↑ 47.81% |
Financing Cash Flow | 14.6M | ↑ 30.58% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -12.4M | ↓ 819.68% |
Investing Cash Flow | -3.8M | ↓ 69.42% |
Financing Cash Flow | 18.3M | ↑ 25.35% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -28.4M | ↑ 128.06% |
Investing Cash Flow | -37.7M | ↑ 888.5% |
Financing Cash Flow | 959.0M | ↑ 5148.37% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -106.6M | ↑ 275.87% |
Investing Cash Flow | -18.9M | ↓ 49.99% |
Financing Cash Flow | -205.2M | ↓ 121.4% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -31.4M | ↑ 0.21% |
Investing Cash Flow | -7.7M | ↑ 58.66% |
Financing Cash Flow | -100.0M | ↑ 4950.51% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.4M | ↓ 82.83% |
Investing Cash Flow | -2.8M | ↓ 63.52% |
Financing Cash Flow | -102.5M | ↑ 2.48% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -13.0M | ↑ 141.24% |
Investing Cash Flow | -21.7M | ↑ 667.85% |
Financing Cash Flow | -2.2M | ↓ 97.86% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 22.0M | ↓ 268.84% |
Investing Cash Flow | -3.2M | ↓ 85.15% |
Financing Cash Flow | -1.5M | ↓ 29.57% |
Sell
Neutral
Buy
Beauty Health Co/the is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Beauty Health Co/the | -17.6% | -26.26% | -69.3% | -74.14% | -74.14% |
Colgate-palmolive Co. | 5.46% | 24.18% | 14.34% | 14.6% | 29.13% |
Estée Lauder Companies Inc. | -7.88% | 21.61% | -33.43% | -53.3% | -22.64% |
Procter & Gamble Company, The | 4.92% | 9.18% | 4.87% | 21.36% | 54.45% |
Kenvue Inc. | -6.0% | -1.29% | -28.92% | -28.92% | -28.92% |
Kimberly-clark Corp. | 8.28% | 14.33% | -6.24% | 1.31% | 7.06% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Beauty Health Co/the | 49.42 | NA | 0.95 | -0.1 | -0.88 | -0.08 | NA | 0.48 |
Colgate-palmolive Co. | 32.08 | 32.08 | 2.15 | 3.49 | 2.79 | 0.15 | 0.02 | 0.74 |
Estée Lauder Companies Inc. | 113.35 | 113.35 | 1.6 | 2.24 | 0.07 | 0.03 | 0.02 | 15.94 |
Procter & Gamble Company, The | 26.4 | 26.4 | 3.28 | 6.55 | 0.32 | 0.11 | 0.02 | 20.87 |
Kenvue Inc. | 20.96 | 20.96 | 2.11 | 1.14 | 0.11 | 0.07 | 0.04 | 5.85 |
Kimberly-clark Corp. | 24.86 | 24.86 | 1.57 | 7.08 | 1.81 | 0.11 | 0.04 | 3.1 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Beauty Health Co/the | Buy | $377.7M | -74.14% | 49.42 | -25.16% |
Colgate-palmolive Co. | Buy | $73.0B | 29.13% | 32.08 | 11.82% |
Estée Lauder Companies Inc. | Buy | $53.4B | -22.64% | 113.35 | 3.08% |
Procter & Gamble Company, The | Buy | $380.7B | 54.45% | 26.4 | 17.99% |
Kenvue Inc. | Buy | $36.1B | -28.92% | 20.96 | 10.77% |
Kimberly-clark Corp. | Hold | $45.5B | 7.06% | 24.86 | 9.05% |
FMR Inc
HHG PLC
Vanguard Group Inc
Luxor Capital Group, LP
Morgan Stanley - Brokerage Accounts
BlackRock Inc
The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.
Organization | Beauty Health Co/the |
Employees | 881 |
CEO | Ms. Marla Malcolm Beck |
Industry | Consumer/Non-Cyclical |